Inventor
Gregory P. Pogue
Inventor
Vacaville, CA, US
Overview
Patents· 16 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
C12Nprimary
C12NMicroorganisms or enzymes30%
C07KPeptides28%
A61KPreparations for medical, dental or toiletry purposes12%
C12QMeasuring or testing processes involving enzymes, nucleic acids or microorganisms8%
Y02ATechnologies for adaptation to climate change8%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations4%
A01HNew plants or non-transgenic processes for obtaining them2%
A01KAnimal husbandry2%
C12PFermentation or enzyme-using processes to synthesise a desired chemical compound or composition or to separate optical isomers from a racemic mixture2%
C12YEnzymes2%
PatentTitleYear
7,939,318'Flexible vaccine assembly and vaccine delivery platform'20117,915,483'C-terminally truncated interferon'20117,432,079'Plant virus coat fusion proteins with GDF8 epitopes and vaccines thereof'20087,413,889'Production of a parvovirus vaccine in plants as viral coat protein fusions'20087,291,767'Nucleic acids compositions conferring dwarfing phenotype'20077,270,825'Production of a parvovirus vaccine in plants as viral coat protein fusions'20077,132,588'Viral expression vectors'20067,049,134'Rolling circle replicon expression vector'20066,855,522'Species-specific PCR assay for detection of Leishmania donovani in clinical samples of kala-azar and post kala-azar dermal leishmaniasis'20056,846,968'Production of lysosomal enzymes in plants by transient expression'20056,800,748'Cytoplasmic inhibition of gene expression and expression of a foreign protein in a monocot plant by a plant viral vector'20046,730,306'Parvovirus vaccine as viral coat protein fusions'20046,656,726'Viral expression vectors'20036,468,745'Method for expressing a library of nucleic acid sequence variants and selecting desired traits'20026,300,134'RNA transformation vectors derived from a single-component RNA virus and contain an intervening sequence between the cap and the 5\' end'20016,300,133'RNA transformation vectors derived from an uncapped single-component RNA virus'2001Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
2001–2007Patents assigned to LARGE SCALE BIOLOGY CORP (10)· patent assignee history
2001–2011Based in Vacaville, CA, US· patent location history
2005Patents assigned to INDIAN COUNCIL MEDICAL RES (1)· patent assignee history
2007Patents assigned to DOW CHEMICAL CO (1)· patent assignee history
2008–2011Patents assigned to KENTUCKY BIOPROC LLC (2)· patent assignee history
2011Patents assigned to BIOLEX THERAPEUTICS INC (1)· patent assignee history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| LARGE SCALE BIOLOGY CORP | 10 | 2001–2007 |
| KENTUCKY BIOPROC LLC | 2 | 2008–2011 |
| BIOLEX THERAPEUTICS INC | 1 | 2011 |
| DOW CHEMICAL CO | 1 | 2007 |
| INDIAN COUNCIL MEDICAL RES | 1 | 2005 |
Locations
| Location | Patents | Span |
|---|---|---|
| Vacaville, California, US | 16 | 2001–2011 |